Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that an abstract highlighting preclinical data from SG293, ...

If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares ...

Biotechnology stocks have seen a spike in merger and acquisition (M&A) activity. In March 2026 alone, there were 10 deals ...

Lunai Bioworks uses a proprietary AI platform and biological validation to reverse-engineer diseases, aiming to reduce the 90 ...

LUND, SE / ACCESS Newswire / April 27, 2026 / Cantargia AB (Nasdaq Stockholm:CANTA), a clinical-stage biotechnology company focused on antibody-based therapeutics targeting IL1RAP, today announced ear ...

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke ...

An early Moderna investor, Platinum Asset Management’s Bianca Ogden is leveraging fresh medical breakthroughs to ride a ...

Transaction expands Ligand's royalty portfolio to more than 200 assets and adds seven new commercial products Bolsters and diversifies Ligand's long-term compounding growth, adding a complementary por ...

The Supreme Court is set to hear arguments Monday in a case that could lead to the dismissal of tens of thousands of lawsuits against Bayer, the pharmaceutical and biotech giant, claiming the ...

Emil Michael was exuberant. In just six months as the Pentagon’s new technology chief, he had met with more than 100 start-ups, he told podcaster Molly O’Shea in December, scouring the tech world for ...

The warning has been issued for parts of Arkansas, Illinois, Indiana, Kentucky, Missouri and Tennessee, US News, Times Now ...

A major new study finds that living in pesticide-heavy environments could raise cancer risk by up to 150%, even when the chemicals are considered “safe” on their own. The research suggests these ...